comparemela.com

Latest Breaking News On - Safety review committee - Page 7 : comparemela.com

NeuroBo Pharma Gets Approval To Proceed With Phase 2a Trial For DA-1241 To Treat MASH; Stock Up 8%

Biotechnology company NeuroBo Pharmaceuticals, Inc. (NRBO) announced Wednesday the receipt of Safety Review Committee (SRC) approval, recommending that the two-part Phase 2a trial of DA-1241 can continue without modification following a blinded safety review of the first six months of study conduct.

Beyond Air, Inc (NASDAQ:XAIR) Q3 2024 Earnings Call Transcript

Operator: Good afternoon, and welcome, everyone, to the Beyond Air Financial Results Call for the Fiscal Quarter ended December 31, 2023. At this time, participants are in a listen-only mode.

Island Pharmaceuticals advances critical study of antiviral drug ISLA-101 against dengue

Island Pharmaceuticals advances critical study of antiviral drug ISLA-101 against dengue
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

Island Pharmaceuticals confirms all doses in ISLA-101 study safe and well tolerated by volunteers

Island Pharmaceuticals confirms all doses in ISLA-101 study safe and well tolerated by volunteers
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

FIVE at FIVE AU: RBA keeps interest rates on hold as ASX dips

FIVE at FIVE AU: RBA keeps interest rates on hold as ASX dips
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.